Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VRCA
#4010
Verrica Pharmaceuticals Inc. Common Stock
5.720
0
USD
+1.78%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+1.78%
Mudança mensal
-6.08%
Mudança em 6 meses
-4.98%
Mudança anual
-4.98%
Fechamento anterior
5.620
0
Abrir
5.720
0
Bid
Ask
Mínimo
5.720
0
High
5.720
0
Volume
25
Mercados
Ações
Cuidados de saúde
VRCA
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
2.54 M
2.75 M
4.19 M
4.24 M
9.18 M
17.18 M
—
Valuation ratios
Enterprise value
319.03 M
278.02 M
86.26 M
263.43 M
49.8 M
113.19 M
255.21 M
Price to earnings ratio
—
—
-4
-4.6
-0.47
-4.95
-7.55
Price to sales ratio
—
—
10.89
60.26
4.79
2.49
11.43
Price to cash flow ratio
—
—
-5.28
-8
-0.6
-5.02
-7.16
Price to book ratio
—
—
2.46
15.62
-3.68
3.58
2.28
Enterprise value to EBITDA ratio
—
-10.4
-4.16
-3.34
-0.27
-9.23
-11.22
Profitability ratios
Return on assets %
-0.58
-0.44
-0.55
-0.82
-1.41
-0.38
-0.4
Return on equity %
-1.29
-1.08
-0.61
-3.39
7.77
-0.72
0.2
Return on invested capital %
-259.12
-209.79
-295.27
-2 367.24
-972.74
-172.89
—
Gross margin %
—
100
100
90.24
65.64
98.59
374.89
Operating margin %
—
-257.57
-235.78
-1 283.35
-871.25
-34.25
-354.42
EBITDA margin %
—
-254.94
-229.52
-1 282.38
-892.92
-34.29
-371.59
Net margin %
—
-292.33
-271.11
-1 307.47
-1 012.15
-50.27
-442.15
Liquidity ratios
Quick ratio
—
—
—
4.49
1.68
2.45
6.06
Current ratio
1.71
1.61
11.31
4.55
1.76
2.59
6.44
Inventory turnover
—
—
—
—
—
0.21
—
Asset turnover
—
0.16
0.14
0.08
0.11
0.7
0.86
Solvency ratios
Debt to assets ratio
0.5
0.52
—
0.54
0.59
0.01
1.88
Debt to equity ratio
1.12
1.28
—
2.23
-3.23
0.02
-4.27
Long term debt to total assets ratio
0.47
0.5
—
0.53
0.57
0
1.82
Long term debt to total equity ratio
1.06
1.23
—
2.17
-3.14
0
-4.17
Per share metrics
Operating cash flow per share
—
—
-5.46
-8.51
-11.76
-1.65
-1.81
EBIT per share
—
—
-6.23
-14.61
-13.23
-1.19
-1.33
EBITDA per share
—
—
-6.07
-14.49
-13.04
-1.15
-1.28
Total debt per share
—
—
—
9.73
6.15
0.05
8.09
Cash per share
—
—
10.03
15.34
1.93
2.83
7.73
Net current asset value per share
—
—
11.45
17.1
9.88
3.99
15.85
Tangible book value per share
—
—
11.72
4.36
-1.9
2.32
-3.27
Working capital per share
—
—
10.44
13.34
4.28
2.45
5.09
Book value per share
—
—
11.72
4.36
-1.9
2.32
-3.27
Notícias
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript
Ações da Verrica Pharmaceuticals sobem após lançamento do YCANTH no Japão
Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan
Verrica’s partner launches molluscum treatment in Japan
Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why
New Strong Buy Stocks for February 2nd
How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%
Ações da Verrica Pharmaceuticals sobem após TD Cowen reiterar recomendação de compra
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating
Verrica dosa primeiro paciente em estudo de fase 3 para tratamento de verrugas comuns
Verrica doses first patient in phase 3 trial for common wart treatment
Verrica Pharmaceuticals nomeia Charles Frantzreb para o conselho e aprova concessões de ações